31.35000 USD
0.65
2.03%
Last update Dec 12, 3:59 PM EST
Market closed
Day range
31.14000
32.30200
Previous close
32
Open
32.16000
Access this stock data via API
Subscribe
TG Therapeutics, Inc.
31.35
0.65
2.03%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 329.0M 233.7M 2.8M 6.7M
Cost of revenue 38.5M 14.1M 265K 790K
Gross profit 290.5M 219.5M 2.5M 5.9M
Operating expense
Research & development 94.3M 76.2M 125.4M 222.6M
Selling general and admin 154.3M 122.7M 70.0M 128.1M
Other operating expenses
Operating income 41.9M 20.6M -192.8M -344.8M
Non operating interest income
Income
Expense 24.0M 12.6M 10.2M 5.6M
Other income expense 7.7M 5.0M 4.7M 2.3M
Pretax income 25.6M 13.1M -198.3M -348.1M
Tax provision 2.2M 390K 0 0
Net income 23.4M 12.7M -198.3M -348.1M
Basic EPS 0.2 0.1 -1.5 -2.6
Diluted EPS 0.2 0.1 -1.5 -2.6
Basic average shares 145.3M 142.0M 135.4M 132.2M
Diluted average shares 145.3M 142.0M 135.4M 132.2M
EBITDA 49.9M 26.1M -187.6M -342.0M
Net income from continuing op. 23.4M 12.7M -198.3M -348.1M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed (non-working day)
Pre-market opens in 4 hours 30 minutes

23:29
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).